FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-2334737, 892128-60-8, LY-2334737 Intermediate 122111-03-9, stock 448g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| LY-2334737, 892128-60-8, LY-2334737 Intermediate 250698-52-3, stock 171.2g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| LY-2334737, 892128-60-8, LY-2334737 Intermediate 99-66-1, stock 639.3g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| LY-2334737, 892128-60-8, LY-2334737 Intermediate 1196664-00-2, stock 335.5g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-2334737, 892128-60-8, LY-2334737 Intermediate 892128-60-8, stock 607.4g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
